Today: 20 June 2026

Lynas Rare Earths share price slips after export-curb rally as traders eye Jan. 21 update

Lynas Rare Earths share price slips after export-curb rally as traders eye Jan. 21 update

Lynas Rare Earths dropped 5.4% to A$14.24 on Thursday, reversing part of Wednesday’s 14.5% surge after China banned exports of “dual-use” items to Japan. The stock traded 8.36 million shares as investors weighed risks to rare earth supply. G7 finance ministers will meet Jan. 12 to discuss supply and a possible price floor. Lynas will report quarterly results Jan. 21.
8 January 2026
·
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 08.01.2026

Royalty Pharma closed at $40.26, up 40% in a year, but a DCF model values shares at $179.83, about 77.6% higher. Camping World Holdings ended at $11.16, with a DCF value of $3.85, suggesting a 190% premium. Photronics traded at $31.78 after a 23.7% monthly gain; DCF analysis estimates intrinsic value at $19.02. Tanger raised $200 million in exchangeable notes and secured $550 million in term loans.
8 January 2026
···
DBS Smashes S$58, OCBC Tops S$20: Singapore Bank Stocks Hit Records as Dividend Hunt Intensifies

DBS Smashes S$58, OCBC Tops S$20: Singapore Bank Stocks Hit Records as Dividend Hunt Intensifies

DBS shares closed at a record S$58.40 after hitting S$58.80, while OCBC touched S$20.25 before easing to S$20.06, driving Singapore’s STI to another high. Dividend yields near 5% have kept buyers active despite stretched valuations. DBS is up over 30% in 12 months; OCBC has gained 19%. Analysts warn earnings pressure could test dividend payouts if credit costs rise.
8 January 2026
····
ServiceNow (NOW) stock rises as Jan. 28 earnings date set — key levels and risks to watch

ServiceNow (NOW) stock rises as Jan. 28 earnings date set — key levels and risks to watch

ServiceNow shares closed up 1.4% at $150.90 Wednesday, marking a third straight gain despite lighter-than-average trading volume. The company will report fourth-quarter and full-year 2025 results after markets close on Jan. 28. Shares remain well below their 50- and 200-day moving averages. Investors await updates on the $7.75 billion Armis acquisition and subscription revenue outlook.
8 January 2026
··
Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings

Danaher stock slips as analysts lift targets ahead of JPM Healthcare Conference, earnings

Danaher shares closed down 0.42% at $235.60 Wednesday, then edged up 0.16% after hours. CEO Rainer Blair will present at the J.P. Morgan Healthcare Conference Jan. 13, with Q4 earnings set for Jan. 28. Evercore ISI and TD Cowen raised price targets to $250 and $270, respectively. The stock traded between $233.26 and $238.00, with 2.7 million shares changing hands.
8 January 2026
··
Microsoft stock closes higher as Musk-OpenAI trial risk lands, with MSFT earnings in focus

Microsoft stock closes higher as Musk-OpenAI trial risk lands, with MSFT earnings in focus

A U.S. judge set Elon Musk’s lawsuit over OpenAI’s for-profit shift for a March jury trial, keeping Microsoft as a defendant. Microsoft shares closed up 1% at $483.47, valuing the company at about $3.85 trillion. Traders are watching Microsoft’s upcoming results for signals on Azure and AI spending. OpenAI reportedly set aside an employee stock pool worth 10% of the company, valued at $500 billion in October.
8 January 2026
···
Alien Talk Fades Around Interstellar Comet 3I/ATLAS as New Searches Find No Signals and Images Turn Green

Alien Talk Fades Around Interstellar Comet 3I/ATLAS as New Searches Find No Signals and Images Turn Green

Astronomers using the Green Bank Telescope detected no radio technosignatures from interstellar comet 3I/ATLAS, supporting its natural origin. Gemini North released an image showing the comet’s green glow from gases near the Sun. NASA’s Europa Clipper spacecraft observed the comet’s tails in ultraviolet, with some features still unexplained, researchers said.
8 January 2026
Bristol Myers Squibb (BMY) stock jumps on UBS upgrade as investors look to January catalysts

Bristol Myers Squibb (BMY) stock jumps on UBS upgrade as investors look to January catalysts

Bristol Myers Squibb shares jumped 4.2% to $56.72 after UBS upgraded the stock to “buy” and raised its price target to $65. UBS cited upcoming catalysts but noted ongoing patent-expiry pressure through 2028. Trading volume exceeded averages as the stock outperformed peers on a down market day. Investors await the company’s Jan. 12 J.P. Morgan conference appearance and Feb. 5 quarterly results.
8 January 2026
·
SpaceX lines up back-to-back Starlink launches from Florida as orbit crowding comes into focus

SpaceX lines up back-to-back Starlink launches from Florida as orbit crowding comes into focus

SpaceX plans to launch 29 Starlink satellites from Cape Canaveral on Jan. 10, following another Starlink mission scheduled for Jan. 8. If both flights proceed, 58 satellites would be added in three days. The company says it is lowering satellite orbits to reduce debris risks as its constellation grows, with over 9,300 Starlinks active as of Jan. 2. Launches use flight-proven Falcon 9 boosters and target droneship landings.
8 January 2026
·
Rocket Companies stock holds near 52-week high after Barclays target hike; mortgage apps drop

Rocket Companies stock holds near 52-week high after Barclays target hike; mortgage apps drop

Rocket Companies shares closed up 0.3% at $21.28 after volatile trading on heavy volume, with the stock up about 10% year-to-date. Barclays raised its price target to $22 but maintained a neutral rating. Mortgage applications fell 9.7% over the holiday-adjusted period, even as rates dropped to 6.25%. Director Matthew Rizik sold 5,000 shares under a pre-set trading plan.
8 January 2026
··
1 … 963 964 965 966 967 … 2,086

Stock Market Today

  • UK Investors Urged to Avoid Poor Quality Stocks to Support London Market
    June 20, 2026, 12:20 AM EDT. UK retail investors are warned against purchasing poor quality or 'rubbish' stocks. Experts say backing weak companies for the wrong reasons harms the London stock market's health and growth prospects. This trend risks undermining investor confidence and market stability, as retail investment plays a crucial role in market dynamics.

Latest articles

JBS shutdowns put pressure on U.S. beef as cattle prices rise

JBS shutdowns put pressure on U.S. beef as cattle prices rise

20 June 2026
JBS USA will close its Souderton, PA, and Memphis, TN, meat plants on August 14, cutting 1,693 jobs as tight cattle supplies drive negative U.S. beef margins; USDA data show beef prices up 14.8% year-over-year and forecast to rise another 12.1% in 2026, signaling ongoing cost pressure for packers and consumers.
TSMC Leads Nvidia in Short Week Chip Gains

TSMC Leads Nvidia in Short Week Chip Gains

20 June 2026
TSMC’s U.S.-listed shares soared 6.9% to $462.12, outpacing Nvidia’s 3.0% gain, as investors favored broad chip manufacturing exposure after an interim U.S.-Iran deal eased inflation fears and Taiwan’s central bank raised its 2026 economic-growth forecast to 9.45% on AI-driven semiconductor demand.
Intel Beats AMD for Week After Trump Comments on Apple Chips

Intel Beats AMD for Week After Trump Comments on Apple Chips

20 June 2026
Intel soared 10.6% to a record $133.99 after President Trump said Apple agreed to work with Intel on U.S. chip design and production, though neither company confirmed terms or details; analysts are split on the deal’s value, with Intel’s gains outpacing AMD’s 4.9% rise as the chip sector hit a record close.
Go toTop